Conditions like inflammatory bowel disease (IBD) have been shown to decrease production (16)

Skin wound healing: acute wounds, slow-healing wounds, and post-traumatic skin repair where collagen remodeling is a clinical priority Post-surgical tissue recovery: skin and soft tissue healing following surgical procedures, particularly where scar minimization and organized collagen deposition are desired Anti-aging and skin rejuvenation: wrinkle reduction, skin firmness, and surface texture improvement through topical or injectable GHK-Cu protocols Hair follicle stimulation: investigated for hair growth support in patients with hair thinning or loss where scalp vascularity and follicle reactivation are clinical targets Gastrointestinal mucosal healing: investigated for ulcerative colitis and GI mucosal repair through SIRT1/STAT3 pathway inhibition Combination wound healing protocols: used alongside BPC-157 and TB-500 to provide copper-dependent enzyme activation and gene expression regulation as part of a comprehensive tissue repair approach GHK-Cu is the peptide most commonly associated with skin applications in physician-supervised peptide therapy, and it occupies a distinct clinical role from the musculoskeletal-focused BPC-157 and TB-500

[107] Anti-seizure medications phenobarbital, pregabalin, primidone and topiramate are associated with lower than normal serum vitamin concentration
Increased urinary bacterial metabolites in neurocognitive disorders
BPC-157's angiogenic effects (improved blood supply) and gut-lining protective signalling both relate to tissue-adjacent outcomes in the research context, which is the basis for the category grouping
Monthly costs typically range from $200-600 for single peptides, with combination protocols reaching $800-1200 monthly